Saturday, August 25, 2012

Chronic Immune Demyelinating Neuropathies: Variants

http://neuromuscular.wustl.edu/antibody/pnimdem.html#variant


Acute onset
β-Tubulin antibodies
Childhood
CNS features
Diabetes
IgM vs GM2 & GalNAc-GD1a
Motor
M-protein: IgM; IgG or IgA
Multifocal
Upper limb
Perineuritis
POEMS
Sensory
Subacute
Typical


  • Multifocal CIDP9
    • Nosology
    • Age range: 28 to 58 years
    • Weakness
      • Asymmetric
      • Distal > Proximal
      • Arms > Legs (78%)
      • Proximal syndrome: Occasional
        • Phrenic nerve: Diphragm weakness; Respiratory insufficiency
        • Suprascapular nerve: Infraspinatus ± Supraspinatus weakness
        • Other scattered distal & proximal muscles
    • Sensory loss: Distal; Pansensory; Rarely severe or disabling
    • Tendon reflexes: Focal loss
    • Course: Slowly progressive, or Relapsing-Remitting
    • Laboratory
      • Electrophysiology
        • Multifocal conduction block
        • Nerve conduction velocities: Variably slow
        • Distal latencies: Variably prolonged
      • CSF protein: High but usually < 100 mg/dL
      • IgM anti-GM1 antibodies: Never
      • MRI: Swollen nerves in brachial plexus with high T2 signal
      • Nerve pathology
    • Treatment: PrednisoneHIG

  • Multifocal upper limb CIDP2,6
    • Male:Female = 1.9:1
    • Onset
      • Mean = 43 to 54 years; Range 9 to 75 years
      • Rarely childhood
      • Acute or Progressive
      • Distal
    • Clinical
      • Weakness
        • Onset: May be motor, sensory, or both; With reduced pain
        • Single or multiple upper extremity nerves
        • Distal > Proximal
        • Asymmetric > Symmetric
        • Monomelic or Bilateral
      • Sensory
        • Paresthesias or numbness early in most
        • Pain: 22%; Often localized to peripheral nerve territory
        • Sensory loss: Usually mild, distal; Often asymmetric
      • Tendon reflexes: Often reduced in involved limb(s)
      • Course
        • Progressive: To legs in 25%
        • Some stabilize or spontaneously resolve
      • Cranial nerves: 17%; Optic; III; VII
      • Rule out: Brachial neuritis
    • Laboratory
      • Anti-GM1 ganglioside antibodies: Uncommon
      • CSF protein
        • High in 40% to 72%
        • Mean 64 mg/dL; Range 21 to 128
      • Nerve conduction studies
        • Conduction block (100%): Proximal or Distal segments
        • Slowing 35%;
        • CMAP amplitude: Reduced (56%)
        • Abnormal SNAPs: Some patients; Up to 83%
        • Leg involvement: 34%
      • MRI
        • Usually normal
        • May have brachial plexus lesions
    • Treatment
      • Response to Prednisone or HIG in some (> 50%)
      • Often less recovery than with generalized CIDP

  • Motor predominant CIDP 36
    • Clinical
      • Onset
        • Age: 8 to 24 years
        • Weakness: Progressive over 1 to 6 months
      • Weakness
        • Distal > Proximal
        • Symmetric
        • Arm predominant or Arms & Legs
        • May be exacerbated by heat (Uhthoff-like phenomenon)
      • Sensory exam: Normal
      • Tendon reflexes: Diffusely absent
    • Laboratory
      • Nerve conduction studies
        • Motor: Distal & F-wave latency long; Conduction block; NCV slowed (17 to 33 M/s
        • Sensory: Normal or reduced SNAP amplitudes
      • CSF: Protein high
      • GM1 antibodies: Not present
    • Differential diagnosis: Multifocal motor neuropathy

  • Sensory CIDP
    • Clinical
      • Sensory
        • Loss: Distal predominant; Pansensory or Small fiber
        • Pain
      • Motor: Normal or minimal distal weakness
      • Tendon reflexes: Normal or Reduced
    • Electrophysiology (NCV): Motor & Sensory demyelination
      • Motor
        • Conduction block
        • NCV: Slow
        • Distal latency: Long
      • Sensory: Slow NCV
    • Treatment: Poor response to prednisone or HIG

  • Childhood CIDP
    • Prevalence: ~ 1 in 300,000; Male > Female
    • Preceding infections or vaccinations: 54%
    • Onset: Childhood to Teens; Rarely infancy
    • Course: Several patterns
      • Monophasic: 25%
        • Peak disability < 3 months
        • Off medications in < 1 year
      • Chronic
        • Persistent weakness & disability
        • Require continued immunosuppression
      • Acute onset: 25%
      • Relapsing: Often treatment related
    • Clinical patterns
      • Overall
      • Weakness: Proximal + Distal; Usually symmetric
      • Sensory loss: Pansensory; Distal; Symmetric
      • Tendon reflexes: Reduced or Absent
      • Other: Rare clinical CNS features
    • Disease Associations
      • Comparison with adult CIDP: Less with M-proteins & Diabetes
      • CNS changes: Rarely reported19
      • Other systems: Renal; Hearing28
    • Prognosis
      • Better for remission with relatively rapid onset
      • Worse: Axonal loss
    • Laboratory
      • Pathology
        • Similar to adult CIDP
        • Chronic cases may have prominent demyelinating features
      • MRI: Gadolinium enhancement of roots very common; Occasional CNS changes
      • Nerve conduction: Similar to adult CIDP
    • Treatment
      • Corticosteroids: Response in > 90%
      • IVIg: Response in > 80%
      • Methotrexate: 2nd line treatment

  • CIDP + IgM M-protein vs β-tubulin
    • Weakness: Slowly progressive; Asymmetric
    • Hyporeflexia
    • Poor response to prednisone
    • Antigenic epitope: β-tubulin amino acids 301-314

  • CIDP associated with IgG or IgA M-protein
    • Similar clinical syndrome to typical CIDP
    • Weakness: Slowly progressive; Symmetric
    • Partial response to immunotherapy

  • CIDP + Diabetes mellitus8
    • Patient characteristics: Most similar to CIDP alone
    • Differences from CIDP
      • Age: Older (67 years)
      • Symptoms: More gait imbalance
      • Electrodiagnostic: More axonal loss
      • Treatment: Less improvement

  • CIDP: Acute onset32
    • Onset: Progressive over days to weeks
    • Clinical
      • Weakness
        • Symmetric
        • Proximal & Distal
        • Uncommon: Face, Tongue, Eye movements, Respiratory failure
        • Less severe than GBS
      • Sensory loss: Distal
      • Tendon reflexes: Reduced
      • Course
        • Slower progression to nadir than GBS
        • Partial, but not complete improvement in strength over months
        • Treatment related exacerbations
          • Common
          • Time of first exacerbation: Median 18 days; Range 10 to 54 days
          • Especially > 8 weeks after onset
          • May occur ≥ 3 times
    • Laboratory
      • Electrodiagnostic
        • Prominent demyelinating features early in disease course
        • More slowing of motor nerve conduction velocity than GBS
        • Conduction block (30%)
        • EMG denervation (75%)
      • CSF protein: High
      • Antibodies: IgG anti-glycolipid uncommon

  • CIDP: Subacute onset23
    • Male > Female: 2 to 1
    • Onset
      • Age: Childhood or Adult
      • Progressive over 4 to 8 weeks
      • Antecedent infection (38%)
    • Clinical
      • Weakness (80%)
        • Symmetric (90%)
        • Proximal & Distal
      • Sensory loss (80%): Distal
      • Tendon reflexes: Reduced
      • Course
        • Improvement with corticosteroid treatment
        • Few relapses
    • Laboratory
      • Electrodiagnostic: Demyelination
        • NCV: Slow
        • Terminal latency: Prolonged (50%)
        • Conduction block: 50%
        • Temporal dispersion: 50%
        • Sensory: Absent SNAPs
      • CSF protein: High
      • Nerve biopsy
        • Demyelination in some: May require teased fibers to document
        • Inflammation: Epineurial; Some patients

  • CIDP + CNS features19
    • Frequency: Rare patients with CNS features
    • Onset
    • CNS features
      • Ocular
        • Papilledema: Associated with high CSF protein
        • Visual loss: Optic atrophy
      • Myelopathy
        • Tendon reflexes may be brisk
        • r/o Spinal cord compression from enlarged nerve roots
      • Ataxia
      • Focal CNS myelin loss: 1 patient
        • CNS: Focal mass-like lesion
        • Weakness: Mild; Distal
        • Sensory loss: Mild vibration
        • Tendon reflexes: Normal
        • NCV: Slow; Long distal latency
      • Multiple sclerosis + CIDP27
        • MS duration at onset: 4 to 22 years
        • Clinical
          • Weakness: Distal > Proximal;
          • Sensory loss: Distal; Pan-modal
          • Tendon reflexes: Reduced or Absent
        • CSF protein: > 120 mg/dL
        • Nerve conduction studies: Demyelinating neuropathy
        • Treatment: IVIg; Corticosteroids
    • Rule out: Late onset dysmyelination (MLDKrabbe)
    • Treatment: Corticosteroids
  • Perineuritis
    • Usually axonal neuropathy: Occcasional demyelinating neuropathy reported

No comments:

Post a Comment